Janus Henderson Group PLC 4 D Molecular Therapeutics, Inc. Call Options Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding FDMT
# of Institutions
148Shares Held
57.4MCall Options Held
55.6KPut Options Held
53.7K-
Ra Capital Management, L.P. Boston, MA5.1MShares$39.3 Million1.61% of portfolio
-
Black Rock Inc. New York, NY4.9MShares$37.8 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY4.4MShares$33.9 Million10.13% of portfolio
-
Goldman Sachs Group Inc New York, NY4.13MShares$31.9 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.1MShares$31.6 Million1.63% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $250M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...